Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
about
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsEquine infectious anemia virus utilizes host vesicular protein sorting machinery during particle releaseGenotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA)Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanismInsensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype BSignificantly longer envelope V2 loops are characteristic of heterosexually transmitted subtype B HIV-1 in TrinidadAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityCross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env GeneCoreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotypeStructure activity relationship of dendrimer microbicides with dual action antiviral activityHuman immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodiesCharacterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissuesSubtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, KenyaRole of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patientsChemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1.Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.Molecular evidence of HIV-1 transmission in a criminal case.Human immunodeficiency virus fusion to dendritic cells declines as cells mature.
P2860
Q24531479-7C29E614-64FB-41AE-B42E-93D09E9F7844Q24561905-3D749B59-32D6-4950-B6E1-8D61630117CAQ24635002-6F5F72E8-AACC-4BF0-BDD3-BA6A2178D101Q24682537-DAF151B6-2296-434F-B91A-A2C8426CC398Q27485356-4D156824-890C-482D-9617-211A4764FDE6Q27635422-E3CE6846-2ADD-4A81-8127-64DF9BA32D5DQ28379257-F441F8BA-3234-4B12-9988-C16D69F87D51Q28469023-8B7030D6-321D-47C3-9F61-5BC17B9A7ACDQ28478624-ECF9F326-1227-4C2B-B43C-368E395B5DBDQ28485983-107125E9-8865-49C9-9C82-ACEA4A9778E8Q28554907-8C5902C4-C109-4CA7-B887-0EDAAA55DBCAQ28646874-E568FE1C-0C7A-4023-9418-78D16C01D592Q28749596-5E42DF95-E8D9-43CE-9770-99FEFC512F25Q29619015-57314504-CF0A-4197-9365-3152350CC670Q30322838-FB0F58F2-11A0-4456-A41B-88A2ABA4B7CFQ30430708-18661782-7000-4F22-BF21-FD491F1196A8Q30485614-B1E1CC4E-7B59-49FA-AE8B-7C427E53997DQ33300529-3083D97C-6FAE-41BB-A8D1-07E85841D105Q33504604-5FD143B8-B226-4E6B-9DE1-E2D7439D5B92Q33567639-57BC902F-13A8-4BB5-BB48-4E4D01E4FDF9Q33570314-887048E5-9762-4052-A798-F5C3F7C2ACCBQ33648259-959E4668-3E57-4B95-85C7-F35E78928155Q33648601-D414B8A4-FFC4-45D6-A145-613F30B73F56Q33653774-777EAA0C-91D5-4765-9604-F867D307E3D3Q33782930-DDD12E33-4D8F-4753-9562-E98DCC6A7D54Q33782982-8E8B1A9D-DCA3-48D4-AC7A-8E8A3907DEEFQ33785473-735A6581-BA66-473D-8FC2-559BE6F78727Q33785770-D0F7D94B-16FD-4963-90A2-A062BE77E07FQ33787352-473F0EEA-5115-4A8F-9C0B-CA9F1723BB38Q33793050-851DE14C-B8B8-4D4C-88BB-E92A2BBC32CBQ33794954-EED49222-99B2-4DCE-9DF9-B3B8B87C63A7Q33817409-F462C20B-694B-4995-8AAF-8073DCA384B3Q33819782-16554079-2EC3-41A1-972B-5FA6CE6B4A3EQ33886113-44D5017C-739E-416B-B7B7-7B4A47AC27B1Q33912373-130EDE6E-837E-4FA6-AB3D-4D77C007B2C5Q33955745-EEEFC268-6ED1-4C75-B1F3-E01EBDA2993BQ33961704-9F9082FA-B148-47AB-8EAB-BB78F75A289BQ34008699-19C0C16A-7FDD-484C-8618-B1371DF067A3Q34155272-6C304296-6BC1-4B58-9B4A-49221029BB8CQ34353507-CEBB86DA-E6B7-4035-B782-41EB2F03CCEB
P2860
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Molecular cloning and analysis ...... solation and Characterization.
@ast
Molecular cloning and analysis ...... solation and Characterization.
@en
type
label
Molecular cloning and analysis ...... solation and Characterization.
@ast
Molecular cloning and analysis ...... solation and Characterization.
@en
prefLabel
Molecular cloning and analysis ...... solation and Characterization.
@ast
Molecular cloning and analysis ...... solation and Characterization.
@en
P2093
P2860
P1433
P1476
Molecular cloning and analysis ...... Isolation and Characterization
@en
P2093
B Galvao-Castro
C L Thornton
D L Robertson
G Karlsson
H von Briesen
P2860
P304
P577
1996-03-01T00:00:00Z